454 related articles for article (PubMed ID: 24607815)
21. The cost effectiveness of radon mitigation in existing German dwellings--a decision theoretic analysis.
Haucke F
J Environ Manage; 2010 Nov; 91(11):2263-74. PubMed ID: 20619957
[TBL] [Abstract][Full Text] [Related]
22. Radon: a likely carcinogen at all exposures.
Darby S; Hill D; Doll R
Ann Oncol; 2001 Oct; 12(10):1341-51. PubMed ID: 11762803
[TBL] [Abstract][Full Text] [Related]
23. Radon and health--an update.
Chaffey CM; Bowie C
J Public Health Med; 1994 Dec; 16(4):465-70. PubMed ID: 7880578
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the individual health benefits accruing from a domestic radon remediation programme.
Denman AR; Phillips PS; Tornberg R; Groves-Kirkby CJ
J Environ Radioact; 2005; 79(1):7-23. PubMed ID: 15571873
[TBL] [Abstract][Full Text] [Related]
25. The cost-effectiveness of residential radon remediation programmes: assumptions about benefits stream profiles over time.
Kennedy CA; Gray AM; Denman AR; Phillips PS
J Environ Radioact; 2002; 59(1):19-28. PubMed ID: 11848149
[TBL] [Abstract][Full Text] [Related]
26. Predicted reduction in lung cancer risk following cessation of smoking and radon exposure.
Ennever FK
Epidemiology; 1990 Mar; 1(2):134-40. PubMed ID: 2073500
[TBL] [Abstract][Full Text] [Related]
27. The impact of declining smoking on radon-related lung cancer in the United States.
Méndez D; Alshanqeety O; Warner KE; Lantz PM; Courant PN
Am J Public Health; 2011 Feb; 101(2):310-4. PubMed ID: 21228294
[TBL] [Abstract][Full Text] [Related]
28. Radon-induced lung cancer in smokers and non-smokers: risk implications using a two-mutation carcinogenesis model.
Leenhouts HP
Radiat Environ Biophys; 1999 May; 38(1):57-71. PubMed ID: 10384956
[TBL] [Abstract][Full Text] [Related]
29. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.
Peto R; Darby S; Deo H; Silcocks P; Whitley E; Doll R
BMJ; 2000 Aug; 321(7257):323-9. PubMed ID: 10926586
[TBL] [Abstract][Full Text] [Related]
30. Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?
Lewis S; Arnott D; Godfrey C; Britton J
Tob Control; 2005 Aug; 14(4):251-4. PubMed ID: 16046688
[TBL] [Abstract][Full Text] [Related]
31. Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study.
Darby S; Whitley E; Silcocks P; Thakrar B; Green M; Lomas P; Miles J; Reeves G; Fearn T; Doll R
Br J Cancer; 1998 Aug; 78(3):394-408. PubMed ID: 9703290
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer epidemiology.
Yoder LH
Medsurg Nurs; 2006 Jun; 15(3):171-4; quiz 175. PubMed ID: 16817299
[No Abstract] [Full Text] [Related]
33. Accounting for smoking in the radon-related lung cancer risk among German uranium miners: results of a nested case-control study.
Schnelzer M; Hammer GP; Kreuzer M; Tschense A; Grosche B
Health Phys; 2010 Jan; 98(1):20-8. PubMed ID: 19959947
[TBL] [Abstract][Full Text] [Related]
34. The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.
Højgaard B; Olsen KR; Pisinger C; Tønnesen H; Gyrd-Hansen D
Scand J Public Health; 2011 Dec; 39(8):785-96. PubMed ID: 21976052
[TBL] [Abstract][Full Text] [Related]
35. A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK.
Coskeran T; Denman A; Phillips P; Tornberg R
Health Policy; 2005 Jan; 71(1):43-56. PubMed ID: 15563992
[TBL] [Abstract][Full Text] [Related]
36. Effects of radon mitigation vs smoking cessation in reducing radon-related risk of lung cancer.
Mendez D; Warner KE; Courant PN
Am J Public Health; 1998 May; 88(5):811-2. PubMed ID: 9585753
[TBL] [Abstract][Full Text] [Related]
37. Residential radon exposure and lung cancer in Sweden.
Pershagen G; Akerblom G; Axelson O; Clavensjö B; Damber L; Desai G; Enflo A; Lagarde F; Mellander H; Svartengren M
N Engl J Med; 1994 Jan; 330(3):159-64. PubMed ID: 8264737
[TBL] [Abstract][Full Text] [Related]
38. p53 Mutations in lung cancer associated with residential radon exposure.
Yngveson A; Williams C; Hjerpe A; Lundeberg J; Söderkvist P; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):433-8. PubMed ID: 10350439
[TBL] [Abstract][Full Text] [Related]
39. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
40. A critical comparison of the cost-effectiveness of domestic radon remediation programmes in three counties of England.
Coskeran T; Denman AR; Phillips PS; Gillmore GK
J Environ Radioact; 2002; 62(2):129-44. PubMed ID: 12171467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
